Always consult with your healthcare provider before starting, stopping, or switching any medication
January 17th, 2025: Study reveals most compounded GLP-1 websites fail to disclose FDA status and safety risks A recent study has highlighted concerns about websites selling compounded versions of popular weight-loss medications, including Novo Nordisks Wegovy and Eli Lillys Zepbound, often without disclosing important safety information
Compounded semaglutide is not the same as FDA-approved Wegovy
In clinical trials for Ozempic (subcutaneous semaglutide for diabetes), diarrhea occurred in approximately 8.5% of patients receiving 0.5 mg and 8.3% of patients receiving 1 mg doses, compared to 4.3% in placebo groups
GIPRs are abundantly expressed on -cells, and their activation induces a rise in cAMP and intracellular calcium levels, facilitating glucose-dependent insulin release from pancreatic -cells (118)
Visibly Life-Changing